We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Ongoing Federal Trade Commission demands for more scientific information to back marketing claims may affect some devicemakers, experts said Tuesday at the Food & Drug Law institute in Washington, D.C. Read More
Effective July 1, devicemakers seeking to register products in Taiwan will need to have their quality system documents approved before submitting an application. Read More
The Centers for Medicare & Medicaid Services and U.S. FDA are establishing an interagency task force to address issues around the regulation of laboratory-developed tests, including LDT quality requirements. Read More
The U.S. FDA’s Center for Devices and Radiological Health is launching a public database of labeling for home use devices and is looking for devicemakers to help test it later this year. Read More
With a June 30 device registration deadline fast approaching, Malaysia’s Medical Device Authority has released more guidance for manufacturers working to list their products. Read More
Health Discovery Corp. may not make any misleading claims about an app purported to diagnose skin cancer, the U.S. Federal Trade Commission says in a final consent order issued April 13.
The consent order follows a February complaint and subsequent comment period. In the complaint, the FTC said there was no scientific data supporting the company’s claim that its MelApp product can evaluate moles for melanoma symptoms. Read More